Exploiting Allosteric Properties of RAF and MEK Inhibitors to Target Therapy-Resistant Tumors Driven by Oncogenic BRAF Signaling is a research paper published in Cancer Discovery (2021). On theSindex it has a DataRank of 0. It has been cited 65 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIH NCI
Grant: R01CA204314
NIH NCI
Grant: R01 CA240362
NIH NCI
Grant: R01CA238229
NIH
Grant: RO1 CA238237
NIH
Grant: U54 CA224070
NIH
Grant: PO1 CA114046
NIH
Grant: R01AT011326
NIH
Grant: R33CA223947
Breast Cancer Research Foundation
Grant: T32CA078207
NCI NIH HHS
Grant: P30 CA010815
NCI NIH HHS
Grant: R01 CA238237
NCI NIH HHS
Grant: P01 CA114046
FWCI
3.48
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals